[ieee 2012 ieee 12th international conference on nanotechnology (ieee-nano) - birmingham...
TRANSCRIPT
2012 12th IEEE International Conference on Nanotechnology (IEEE-NANO)
The International Conference Centre Birmingham
20-23 August 20112, Birmingham, United Kingdom
Abstract— The disinfectant loaded micelle fabrication were
investigated as a carrier for 2-benzyl-4-chlorophenol (OBPCP),
a disinfectant agent. Micelles were assessed in terms of the drug
entrapment efficiency by suitable fabrication process. Results
showed that a film sonication method provided the highest drug
loading density at 16.35 ± 0.52%. To utilize numerous
advantages of these polymer micelles, micelles containing
OBPCP were coated on the surface of catheters using Layer-by-
layer (LbL) dip coating technique, highlighting the protocol as
an improvement in the prolong release of the drug from a
period of several hours to several weeks.
I. INTRODUCTION
Over the past few decades, there has been a lot of
research focus on the drug delivery systems using polymeric
micelles as drug carriers. Polymeric micelles are nano-size
particles that have a size between 10 to 100 nanometer and
fabricated by self-assembly of block copolymers or graft
copolymers. Hydrophobic segment assemble at core of
particles while hydrophilic segment covers the core of the
particle (brush-like protective corona). These particles are
able to collect hydrophobic drugs inside. They have shown
the ability to solubilize hydrophobic drugs where the
solubility of paclitaxel, an anticancer drug, is increased from
0.0015 to 2 mg/ml [1] and micelles also enhance drug
pharmacokinetics [2]. Moreover, an entrapment of the drug
using these micelles can enhance delivery efficiency and
reduces the side effects [3]. A 2-benzyl-4-chlorophenol
(OBPCP) is usually coated on medical surface which is used
as chemicals disinfectant for protection and decreasing the
risk of infection due to rapidly inactivate microorganisms
and chemical structure as shown in Fig. 1(c). The
conventional method for coating antibacterial substances is
the direct coating on medical surface providing a high dose at
a local site without exceeding drug concentration in the
systemic toxicity level. However, the problem arose from the
limited release time of the antibacterial substances where the
effectiveness declines and vanishes within a few hours or
days. This resulted in the cause of bacterial related infection
which can lead to death in some cases.
*This research project is supported by Mahidol University.
H. Pheungkham, C. Nagambenjawong, and M. Theerasilp are with the Biomedical Engineering Department, Mahidol University, Nakorn Pathom,
73170 Thailand.
N. Nasongkla is with the Biomedical Engineering Department, Mahidol University, Nakorn Pathom, 73170, Thailand (Corresponding author to
provide phone: 662-889-2138 ext 6357; fax: 662-899-2138 ext 6367; e-mail:
Figure 1. Chemical structure of (a) Poly(ethylene glycol)-b-poly( -caprolactone) (PEG-b-PCL), (b) Poly(acrylic acid) (PAA), (c) 2-benzyl-4-
chlorophenol (OBPCP).
Layer-by-Layer (LbL) deposition is one of the most used
thin film fabrication techniques. The films can be formed by
deposition of alternating layers of oppositely materials
properties. It can be used in many applications including
controlled drug release, biosensors, and cell patterning [4].
The films can be coated on any geometry of substrates such
as orthopedic implants, stents, and catheter. This technique
can control inter-diffusion and increase drug loading. Films
can be created through electrostatic interactions, covalent
interactions, and hydrogen bonding generating coatings with
various thicknesses ranging from several nanometers to
micrometers. Therapeutics agents can be incorporated into
these multilayer films either directly or within a carrier such
as micelles.
The objective of this study is to improve loading
efficiency of OBPCP through encapsulation inside polymeric
micelles for the control release from the medical device
surface. The amphiphilic block copolymers between
poly(ethylene glycol) (PEG) and poly(ε-caprolactone) (PCL)
were used in this study because of their excellent properties,
including biocompatibility, low toxicity, as well as an
absence of antigenicity and immuno-genicity. OBPCP
containing micelles were prepared by 3 different methods,
namely the dialysis, solvent evaporation and film sonication
technique [5]. Then, OBPCP-micelles were on surface of
substrate by LbL technique base on hydrogen bonding
interaction between poly(acrylic acid) (PAA) as hydrogen-
bond donor and hydrophilic segment of micelles as
hydrogen-bond acceptor. Advantage of using hydrogen bond
interaction is suitable for the surface delivery of hydrophobic
and neutral drugs, which cannot undergoes electrostatic
interaction to form polyelectrolyte multilayers. Films could
be prepared to have high drug loading efficiency as high as
90 wt% as previously studied by Hammond et al [6]. The
surface composition of the PEG-b-PCL/PAA film was
confirmed by ATR-FTIR spectroscopy and demonstrated the
extended release behavior of drug from the prepared film
over a period of several weeks.
Preparation and Characterization of Polymeric Micelles for
Disinfectant Coating of Catheters.
Hathaichanok Pheungkham, Chayanon Ngambenjawong, Man Theerasilp, and Norased Nasongkla
2012 12th IEEE International Conference on Nanotechnology (IEEE-NANO)
The International Conference Centre Birmingham
20-23 August 20112, Birmingham, United Kingdom
II. MATERIALS AND METHODS
A. Materials
PEG-b-PCL (PEG and PCL, Mw = 5 and 5 kDa) was synthesized according to the method developed by Nasongkla et al [7] and chemical structure as shown in Fig. 1(a). Silicone substrates (0.5 in. diameter and 4 in. length) were purchased from supplier. PAA (Mw = 100 kDa) (chemical structure as shown in Fig. 1 (b)) and other reagents were purchased from Acros Organics (NJ, USA).
B. Preparation and characterization of OBPCP-micelles
with difference methods.
Three different methods (dialysis (DS), solvent
evaporation (SE), film sonication (FS)) were used to prepare
OBPCP-micelles. For all fabrication methods, a 10% w/w
theoretical OBPCP loading were used unless otherwise
stated.
1) Dialysis method, this procedure was carried out by
dissolving 1 mg of OBPCP and 9 mg of diblock copolymer
in THF. The mixture solution was transferred to a dialysis
tubing (MWCO = 50 kDa) and dialyzed against water
overnight at 4 C. Then, the micelle solution was filtered
through centrifugal filter devices with a MWCO of 50 kDa to
remove OBPCP sequential centrifugation until no observable
changes in the retained volume.
2) Solvent evaporation method, this procedure was carried
out by dissolving 1 mg of OBPCP and 9 mg of diblock
copolymer in THF and transferred to an aqueous solution.
The mixture was sonicated at the power level of 60% for 1
min. Next, the solution was gently stirred at room
temperature until the organic phase completely evaporates.
Free OBPCP was then removed from the micelle solution
using the same method as described above.
3) Film sonication method, this procedure was carried out
by dissolving 1 mg of OBPCP and 9 mg of diblock copolymer in THF. Solvent was evaporated to yield a solid
film, to which 10 mL of water was subsequently added and
then vigorously sonicated at a power level of 60% for 1 min.
Free OBPCP was then removed from the micelle solution
using the same method as described above.
Then the particle size of OBPCP-micelles, drug loading,
and in vitro release of OBPCP from micelles were
determined by previously study by Nasongkla et al [7].
Loading density, yield and loading efficiency of OBPCP
were then determined utilizing the following set of equations
(1), (2), and (3), respectively:
C. Preparation of LbL film by dip coating technique
Two distinct substrates with (Section D) and without
coating the substrate surface by diblock copolymers were dip
coated. Firstly, the substrates were dipped into PEG-b-PCL
micelle solution (400 mg/L, pH 2.5) for 10 min and rinsed
with water (pH 2.5) to remove weakly bond for 1 min. Then,
the substrates were immerged into PAA solution (1.44 mg/L,
pH 2.5) for 10 min and rinsed again with water (pH2.5) for 1
min. This cycle provides a bilayer of PAA and OBPCP-
micelles. The dipping process was repeated until the desired
number of bilayers was obtained as shown in Fig. 2. Control
experiment was carried out by pure-OBPCP dip coating
substrate at the same number of layers.
D. Coating the substrate surface by block copolymers
This procedure was carried out by dissolving diblock copolymer (PEG (5 kDa)-b-PCL (12.6 kDa)) in organic solvent and transfer to water. It should be noted that the concentration of diblock copolymer used in this step is lower than the known critical micelle concentration (55.69 mg/L). This is to ensure that polymers are predominantly in the dissociated free polymer chains rather than micellar architecture. Then, the substrates were immerged into mixture solution and sonicated at a power level of 60% for 1 min. The process was repeated until the desired number of layers was obtained.
Figure 2. Schematic of layer-by-layer deposition used to assemble from
PEG-b-PCL/PAA films on support substrates.
E. Characterization of the qualitative of LbL film coating
Each layer of films was analyzed by ATR-FTIR
spectroscopy. PAA and the PEG-b-PCL polymer in the film
were recorded by Nicolet 6700 for a total of 64 scans at a
resolution of 4 cm-1
.
F. OBPCP-loading content on substrate determination
After surface coating, the substrates were rinsed three
times with acetone for 3 min. Then, the solvent was
evaporated to yield solid samples and dissolved in a mixture
solvent of DMSO and chloroform (1:1 v/v) before subjected to the UV-Vis analysis. The absorbance of the micelle
solution at 288 nm was measured to determine the OBPCP
content using the previously established calibration curve.
2012 12th IEEE International Conference on Nanotechnology (IEEE-NANO)
The International Conference Centre Birmingham
20-23 August 20112, Birmingham, United Kingdom
G. In vitro release of OBPCP from the substrates
After substrate was coated, enclose substrate in dialysis
bag before immersing in phosphate buffer saline solution
(PBS) in order to measure only the free drug released from
micelles into the solution. OBPCP-micelles coatings
substrates will be immersed into 15 mL of PBS (pH 7.4) in
dialysis tubing with a MWCO of 50 kDa and transferred into
80 mL of PBS. Release studies were performed at 37°C in a
shaker-incubator. At selected time intervals, the buffer
solution outside the dialysis tubing was removed and superseded with fresh buffer solution. OBPCP
concentrations were determined based on absorbance of the
UV-Vis analysis at wavelength 282 nm. Experiments were
performed in triplicate for the both conditions of film
coating.
III. RESULTS AND DISCUSSION
A. Characterization of OBPCP-micelles with difference
micelles fabrication methods.
OBPCP-loaded micelle size of each the fabrication
methods was measured by dynamic light scattering (Table 1).
At 10% theoretical loading, these three distinct methods
provided micelles with suitable size. The dialysis and solvent
evaporation method produced micelles at 28.28 ± 0.56 nm
and 34.05 ± 0.88 nm, respectively where the film sonication
method produced micelles with a slightly greater mean
diameter (43.16 ± 2.08%). This is due to the increased
OBPCP-loaded within the micelle core [8].
Moreover, micelle preparation method was found to affect
the drug loading (Table 1). At 10% theoretical loading, the
dialysis method provided the lowest drug loading (7.07±
1.49%), loading efficiency (57.91± 11.44%) and micelle
yield (64.62 ± 1.88%). This is due to the fact that OBPCP
lost into the surrounding aqueous medium during dialysis
process. The solvent evaporation method is another widely
used method for micelle fabrication, and we successfully
fabricated polymeric micelles with high OBPCP loading
(9.21± 0.07%). However, both the dialysis and solvent
evaporation methods have slow processes of micellar
formation. They require the time for remove organic solvent.
Conversely, the film sonication method had the shortest
processes than the other micelle preparations. Among all
three fabrication methods, this method produced the highest
OBPCP loading with 9.35 ± 0.075% drug loading, loading
efficiency of 87.11 ± 8.33%, and micelle yield of 43.16 ±
2.08%. With a subsequent increase in theoretical drug
loading to 20%, OBPCP loading in micelles increased to
16.5 ± 1.0%. Taken together, all the data indicated that the
film sonication method created the highest OBPCP loading
in micelles compared to all the fabrication methods.
TABLE I
PEG-b-PCL MICELLES PARAMETERS FROM DIFFERENT
FABRICATION PROCEDURES
Micelle
fabrication
method
Theoretical
Loading
(%)
Micelle size
(nm)
Yield (%) Loading
efficiency (%)
Loading
density (%)
DS
SE
FS
10
10
10
15
20
28.28 ± 0.56
34.05 ± 0.88
43.16 ± 2.08
42.50 ± 1.44
44.16 ± 0.78
64.62 ± 1.88
78.16 ± 4.70
84.56 ± 1.29
77.93 ± 0.96
78.44 ± 3.70
57.91 ± 11.44
70.18 ± 4.16
87.11 ± 8.33
75.99 ± 4.81
70.30 ± 4.78
7.07 ± 1.49
9.21 ± 0.07
9.35 ± 0.75
11.59 ± 0.70
16.35 ± 0.52
B. Characterization of the qualitative of LbL film coating
The surface composition of the PEG-b-PCL/PAA film was
confirmed by ATR-FTIR spectroscopy where the peak
corresponding to hydrogen bonding was observed as shown
in Fig. 3. Moreover, the fully protonated PAA peak
(carboxylic acid groups was detected at 1700 cm-1
) without
any peak at 1570 cm-1
(carboxylate anion).
Figure 3. FTIR-ATR spectra of PEG-b-PCL/PAA film on the substrate at
pH 2.5.
C. Micelle-coating content on substrates
The integration of block copolymer micelles into LbL
films by hydrogen bond interaction can increase micelle
content on the surface as shown in Fig. 4. OBPCP containing
micelles increased the OBPCP content on substrate up to 5-
folds, compare to pure-OBPCP dip coating. It should be
noted that there was no difference in the amount of coating
content between non-modified and modified surface with
PEG-b-PCL.
Figure 4. Comparison of OBPCP loading on substrate from different
techniques.
2012 12th IEEE International Conference on Nanotechnology (IEEE-NANO)
The International Conference Centre Birmingham
20-23 August 20112, Birmingham, United Kingdom
D. In vitro release of OBPCP from the substrates
Fig. 5 shows that coating substrates by OBPCP
micelles/PAA LbL could prolong the release and reduce
burst release of OBPCP compared to pure-OBPCP dip
coating substrate. The results showed that OBPCP
completely released from substrate within only one day
where micelles/PAA LbL could prolong the release up to one
month. This is due to hydrogen-bonded LbL films
disintegration upon external pH environment changes. The
carboxylic acid group in PAA used as a hydrogen bond
donor is deprotonated above its critical pH (pKa 4.5).
When OBPCP micelles/PAA-coated substrates were
immerged in physiological conditions, the film deposited on
a substrate gradually disintegration to phosphate buffered
saline at pH 7.4. Moreover, the modification of substrate
surface by block copolymer also play a role in the control of
drug release rate where the substrate that modified with
block copolymer clearly provided slower release than non-
modified surface substrate, possibly due to hydrophilic
segment of block copolymer at the first layer increasing
stability of micelles on the surface.
Figure 5. In vitro release of OBPCP from the substrates into PBS buffer at pH 7.4 (a) accumulative OBPCP release (mg) and (b) accumulative
OBPCP release (%w/w).
IV. CONCLUSION
The results of this study showed that OBPCP was
successfully encapsulated in polymeric micelles with good
yield and loading efficiency. Polymeric micelles loaded with
OBPCP could be coated on the hydrophobic surface and
provided high coating content and prolonged release time.
These coating techniques could potentially be applied as a
film coating to the surface of biomedical devices such as
stents, catheters, and other biomedical implants.
ACKNOWLEDGMENT
This research was supported by National Research
Council of Thailand.
REFERENCES
[1] Kim, T.Y. et al. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients
with advanced malignancies. Clin Cancer Res 10, 3708-3716 (2004).
[2] N. Nasongkla, E. Bey, J. Ren, H. Ai, C. Khemtong, J. S. Guthi, S. F. Chin, A. D. Sherry, D. A. Boothman, and J. Gao, "Multifunctional
polymeric micelles as cancer-targeted, MRI-ultrasensitive drug
delivery systems," Nano Lett., vol. 6, pp. 2427-2430, Nov. 2006. [3] Lavasanifara, J. Samuel, and G. S. Kwon, “Micelles self-assembled
from poly(ethylene oxide)-blockpoly(N-hexyl stearate L-aspartamide)
by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B,” Journal of Controlled Release,
77, pp. 155-160, 2001. [4] Kharlampieva, E., Koziovskaya, V., Sukhishvili, S.A. “Layer-by-layer
hydrogen-bonded polymer films: From fundamentals to applications”
Advanced Materials, 21 (30), pp. 3053-3065, 2009. [5] Blanco, E., Bey, E.A., Dong, Y., Weinberg, B.D., Sutton,
D.M., Boothman, D.A., Gao, J. “β-Lapachone-containing PEG-PLA
polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells,” Journal of Controlled Release,
122 (3), pp. 365-374, 2007.
[6] Kim B.-S., Park, S.W., Hammond, P.T. “Hydrogen-bonding layer-by-layer-assembled biodegradable polymeric micelles as drug delivery
vehicles from surfaces,” ACS Nano, 2 (2), pp. 386-392, 2008.
[7] Pungkham, H.,Swatdipakdi, N.,Theerasilp,M.,Karnkla,S.,Chittchang, M.,Ploypradith, P.,Nasongkla, N. “PEG-b-PCL and PEG-b-PLA
polymeric micelles as nanocarrieres for lamellarin N delivery” Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, pp. 3245-3248, 2011.
[8] Torchilin VP. “Targeted polymeric micelles for delivery of poorly
soluble drugs,” Cell Mol Life Sci, 61(1920), pp. 2549-2559, 2004.